Vitamin E (Tocopherol Alpha)
Vitamin E is the nutritional term for the group of naturally occurring tocopherol and tocotrienols. Vitamin E is naturally present in oils and fats. The dietary vitamin E are absorbed together with chylomicrons and distributed in plasma by other lipoproteins. It is largely stored in adipose tissues, and the measurement of fasting serum/plasma level of vitamin E reflects the individual’s reserve status.
Vitamin E has several important functions. It acts as a scavenger for the molecular oxygen and free radicals and inhibits the lipid peroxidation. It is also necessary for cellular respiration, neurologic and reproductive functions, protection of red cells from hemolysis, and prevention of retinopathy in premature infants. Vitamin E promotes the synthesis of prostacyclin in endothelial cells and inhibits the formation of thromboxanes in thrombocytes, thereby minimizing the aggregation of thrombocytes at the surface of the endothelium. In recent years, there has been a growing interest in linking vitamin E with atherosclerosis and other chronic diseases. Premature and low birth weight infants are particularly susceptible to vitamin E deficiency due to poor placental transfer and limited adipose tissue.
Vitamin E deficiency is characterized by motor and sensory neuropathies, edema and hemolytic anemia. Premature infants who require an oxygen-enriched atmosphere are at increased risk for bronchopulmonary dysplasia and retrolental fibrosis. Supplementation of vitamin E has been shown to be beneficial to reduce the risk in premature infants. Symptoms of vitamin E deficiency are rare in children and adults, but may occur with chronic defect in intestinal absorption of fats as seen in cystic fibrosis and chronic cholestasis. Low vitamin E may also be associated with abetalipoproteinemia. In the rare cases, the deficiency can also occur due to mutation in α-tocopherol transfer proteins (α-TPP) leading to a decrease in distribution of vitamin E throughout the body.
- Useful in clinical assessment of individuals with motor and sensory neuropathy
- Useful in assessing the premature infant requiring oxygenation
- Useful in evaluation of person with intestinal malabsorption of lipids
- Can be used as a marker of oxidative stress
- Can be used as a marker of malnutrition
Increased in:
- Hypervitaminosis E
- Thrombophlebitis
Decreased in:
- Neuropathy
- Bowel disease
- Pancreatic disease
- Chronic cholestasis
- Celiac disease
- Cystic fibrosis
- Arteriohepatic dysplasia
- Rubella-related embryopathy
- Biliary atresia
- Abetalipoproteinemia
- Genetic mutation in α-tocopherol transfer proteins (α-TPP)
| Population / Age Group | Reference Range |
| Adult | 5.5 – 18.0 mg/L [12-42 umol/L] |
| Term infant (Cord blood) | 1.8 – 5.8 mg/L |
| 4 months – 1 year | <9.1 mg/L |
| 1–2 years | 2.9 – 16.6 mg/L |
| 3–5 years | 5.5 – 11.8 mg/L |
| 6–8 years | 4.6 – 14.8 mg/L |
| 9–11 years | 6.2 – 14.3 mg/L |
| 12–17 years | 3.7 – 12.4 mg/L |
| Population | Values Indicating Need for Supplementation |
| Adult | <4.0 mg/L |
| Premature | <2.0 mg/L |
| Neonate | <2.0 mg/L |
| Children | <3.0 mg/L |
| Population | Value Indicating Significant Excess |
| Adult | >40.0 mg/L |
High Performance Liquid Chromatography (HPLC), chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST) or Plasma (EDTA).
Stability
- Ambient: 24 hours
- Refrigerated: 7 days
- Frozen: 28 days
- Adv Nutr. 2014 Sep;5(5):503-14. [PMID: 25469382]
- Clin Chem. 1993;39:2229-34. [PMID: 8222214]
- Am J Clin Nutr. 1983;37:1020-4. [PMID: 6846234]
- J Am Coll Nutr. 2006;25:292-9. [PMID: 16943450]
- Shenkin A, Roberts NB. “Vitamins and Trace Elements.” In: Textbook of Clinical Chemistry and Molecular Diagnostics, 5th ed. 2012. Page 895-983.